| 常用名 | 2,2’-磺酰基双(3,4,6-三氯苯酚) | CAS号 | 1638-41-1 |
|---|---|---|---|
| 价格 | 纯度 | 98.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: p38 MAP Kinase Inhibitor IV is an ATP-competitive inhibitor of p38α/β MAPK with IC50 values of 130 nM for p38α and 550 nM for p38β. It is much less active with ≤23% inhibition at 1 μM against p38γ/σ, ERK1/2, and JNK1/2/3. Shown to be more effective than SB 203580 in inhibiting LPS-induced IL-1β release from hPBMC (100% vs. 50% inhibition with 100 μM inhibitor). A recent study showed that p38 MAP Kinase Inhibitor IV could consistently and significantly enhance reprogramming and iPS cell generation from somatic cells. 物理化学性质: CAS号:1638-41-1 常用中文名:2,2’-磺酰基双(3,4,6-三氯苯酚) 常用英文名:p38 MAP Kinase Inhibitor IV 分子式:C12H4Cl6O4S 分子量:456.94100 密度:1.854 g/cm3 沸点:590ºC at 760 mmHg 熔点:N/A 闪点:310.6ºC 储存条件:-20°C,密闭,干燥 |